Thomas Keyserling, M.D., MPH, is an internist with formal training in epidemiology and is associate professor in the Division of General Medicine and Clinical Epidemiology, Department of Medicine, University of North Carolina Chapel Hill School of Medicine.
Thomas Keyserling has been responsible for much of the design, implementation, and analysis components of several NIH, CDC, and NCI-funded randomized trials testing behavioral interventions to reduce risk factors for cardiovascular disease and cancer. More recently, Dr. Keyserling’s research has focused on behavioral intervention programs designed to improve self-care for African Americans with type 2 diabetes. He was principal investigator of the New Leaf Diabetes study, a study designed to develop and evaluate a clinic- and community-intervention for African American women with diabetes. Dr. Keyserling led a CDC-funded project, “A Church Based Intervention to Improve Diabetes Care,” that involved 24 African American churches and showed a significant reduction in A1c attributable to the behavioral intervention. Dr. Keyserling has also served as co-investigator on the CDC-funded WISEWOMAN projects, providing expertise on study design and measurement of dietary intake, including biomarkers. Currently, Dr. Keyserling is principal investigator of the University of North Carolina at Chapel Hill’s Collaborating Center for the Cardiovascular Health Intervention Research and Translation Network, funded by CDC’s Prevention Research Center program.
Dr. Keyserling has served in the National Health Service Corps in rural North Carolina and was a Robert Wood Johnson Clinical Scholar at UNC. Dr. Keyserling is an active primary care internist and preceptor for internal medicine residents at the UNC General Medicine Clinic in Chapel Hill. He has also served on the UNC School of Medicine IRB for several years.